Discover Codexis' Q3 2025 earnings highlights, strategic shift with Merck, and new leadership—positioning for growth in oligonucleotide manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback